| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 1 | — | — | — | 1 | — | — | — | — | — | — |
| Sell | — | — | 1 | — | 1 | 2 | — | — | 2 | — | 2 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.80 |
—
—
—
—
|
| 2025 | 1.80 |
—
—
—
—
|
| 2024 | 1.80 |
—
—
—
—
|
| 2023 | 2.25 |
—
—
—
—
—
|
| 2022 | 1.80 |
—
—
—
—
|
| 2021 | 1.68 |
—
—
—
—
|
| 2020 | 1.60 |
—
—
—
—
|
| 2019 | 1.48 |
—
—
—
—
|
| 2018 | 1.32 |
—
—
—
—
|
| 2017 | 1.16 |
—
—
—
—
|
| 2016 | 1.25 |
—
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 3,365.00 | 5,801.00 | 9,502.00 | 10,165.00 |
| Receivables | 29,843.00 | 28,750.00 | 28,012.00 | 27,225.00 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 33,208.00 | 34,551.00 | 37,514.00 | 37,390.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 168,706.00 | 176,024.00 | 186,276.00 | 190,919.00 |
| ST’ Debt | 250.00 | 300.00 | 400.00 | 400.00 |
| Other | — | — | — | — |
| 168,956.00 | 176,324.00 | 186,676.00 | 191,319.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 5,306.00 | 4,542.00 | — | — |
—
|
| ’25 | 4,691.00 | 4,044.00 | 4,555.00 | 4,922.00 |
18,212.00
|
| ’24 | 4,116.00 | 5,153.00 | 4,111.00 | 5,062.00 |
18,442.00
|
| ’23 | 3,814.00 | 2,929.00 | 4,203.00 | 699.00 |
11,645.00
|
| ’22 | 4,720.00 | 5,577.00 | 4,672.00 | 3,841.00 |
18,810.00
|
| ’21 | 4,534.00 | 4,851.00 | 5,241.00 | 3,089.00 |
17,715.00
|
| ’20 | 4,425.00 | 3,517.00 | 5,361.00 | 4,136.00 |
17,439.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 138.00 | (558.00) | — | — |
—
|
| ’25 | (272.00) | 1,013.00 | (1,141.00) | 233.00 |
(167.00)
|
| ’24 | (1,343.00) | (859.00) | (27.00) | 222.00 |
(2,007.00)
|
| ’23 | (774.00) | 522.00 | 46.00 | (1,868.00) |
(2,074.00)
|
| ’22 | 476.00 | 1,889.00 | 650.00 | 594.00 |
3,609.00
|
| ’21 | (642.00) | 411.00 | 339.00 | (325.00) |
(217.00)
|
| ’20 | 455.00 | 516.00 | (630.00) | 193.00 |
534.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 138.00 | (558.00) | — | — |
—
|
| ’25 | (272.00) | 1,013.00 | (1,141.00) | 233.00 |
(167.00)
|
| ’24 | (1,343.00) | (859.00) | (27.00) | 222.00 |
(2,007.00)
|
| ’23 | (774.00) | 522.00 | 46.00 | (1,868.00) |
(2,074.00)
|
| ’22 | 476.00 | 1,889.00 | 650.00 | 594.00 |
3,609.00
|
| ’21 | (642.00) | 411.00 | 339.00 | (325.00) |
(217.00)
|
| ’20 | 455.00 | 516.00 | (630.00) | 193.00 |
534.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.10) | 6.72 | — | — |
—
|
| ’25 | (4.41) | 3.80 | 2.12 | 3.80 |
5.83
|
| ’24 | 6.93 | 5.11 | (3.29) | 9.63 |
18.41
|
| ’23 | (5.37) | 2.94 | 4.79 | (7.35) |
(4.92)
|
| ’22 | 0.58 | 1.34 | (15.17) | 0.01 |
(13.10)
|
| ’21 | 1.16 | 3.34 | 1.68 | 1.20 |
7.43
|
| ’20 | 0.15 | (0.49) | 2.01 | 0.74 |
2.56
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.61 | 18.50 | 25.10 | 27.58 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 76.40 | 36.50 | 36.98 | 46.71 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11,316 | 11,024 | 9,783 | 9,423 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.66 | 1.06 | 1.89 | 1.93 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18,810.00 | 11,645.00 | 18,442.00 | 18,212.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.05% | (7.02%) | 23.63% | 8.59% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,725.00 | (1,148.00) | 4,022.00 | 1,338.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.17% | (9.86%) | 21.81% | 7.35% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,358.00 | (752.00) | 3,275.00 | 1,177.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (42.00) | (38.00) | — | — | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 109.98 | 68.68 | 108.10 | 99.70 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | (13.02) | (4.92) | 18.66 | 5.94 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.10 | (12.23) | (11.76) | (0.91) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.10 | (12.23) | (11.76) | (0.91) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 29.83 | 40.65 | 48.47 | 59.70 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 171.04 | 169.56 | 170.60 | 182.67 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.00 | 1.70 | 8.08 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.28 | 0.40 | 0.29 | 0.45 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.28 | 0.78 | 0.74 | 0.82 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.45 | 0.62 | 0.31 | 0.27 | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.32 | (3.48) | (2.87) | (29.33) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,609.00 | (2,074.00) | (2,007.00) | (167.00) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,609.00 | (2,074.00) | (2,007.00) | (167.00) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (137,177.00) | (135,748.00) | (141,773.00) | (149,162.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,455.00 | 5,949.00 | 6,156.00 | 6,266.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,112.00 | 2,584.00 | 355.00 | (3,236.00) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,102.00 | 6,893.00 | 8,269.00 | 10,906.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 0.38% | (0.24%) | 0.83% | 0.27% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.28% | (5.39%) | 31.58% | 12.75% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.92% | (16.64%) | 48.28% | 12.63% | — | — | — |
ROE
|
Lincoln National Corporation (LNC) is roaring back from a brutal 2022-2023 downturn, with 2024 delivering a stunning 58% revenue surge to $18.4 billion, EBT exploding 450% to $4 billion, and ROE hitting a jaw-dropping 48.3%—dwarfing historical norms. After a 38% revenue plunge in 2023 tied to rate hikes and investment losses, the life insurance giant has stabilized its balance sheet, boosting book value per share 62% to $48.47 while deleveraging to a near-net-cash position. Stock price has climbed 63% above 2023 lows, yet trades at fire-sale valuations: PE of 1.70, PS of 0.29, and PB of 0.74—6% below average analyst targets and a tantalizing 42% shy of the high end.
Projections fuel the fire: revenue growing 5-9% annually through 2027 to $20.8 billion, EPS compounding at 9%+ to $8.30, and margins expanding on fixed annuities and retirement tailwinds amid aging demographics. Restructuring—exiting drags like group benefits—positions LNC for disruption in a $1 trillion market, with AI underwriting and digital shifts as hidden accelerators. While insider selling tempers enthusiasm and rate cuts pose risks (hedged by product mix), the asymmetry screams opportunity: a reinvention play trading at a 14% book discount.
Dive into the full analysis for the charts, correlations, and contrarian risks that make LNC’s liftoff primed—don’t miss this undervalued powerhouse’s next leg up.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.